What is InGel Therapeutics worth?
$17.0Mlast known valuation
InGel Therapeutics last raised $350K in its Seed Round (Jul 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for InGel Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2022 | Seed Round | $350K | ▮ | ▮ |
How InGel Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For InGel Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is InGel Therapeutics worth?
- InGel Therapeutics's last known valuation is $17.0M.
- How much has InGel Therapeutics raised?
- InGel Therapeutics has raised $10.8M in total funding across 1 recorded rounds.
- When did InGel Therapeutics last raise?
- InGel Therapeutics last raised in Jul 2022 (Seed Round), raising $350K.